Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
35.97
-0.01 (-0.04%)
Jul 22, 2024, 10:22 AM EDT - Market open

BHVN Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021
Market Capitalization
3,1823,434946-
Market Cap Growth
378.82%262.97%--
Enterprise Value
2,9203,080476-73
PE Ratio
--8.41-1.66-
PB Ratio
10.548.021.76-
P/FCF Ratio
-12.41-10.26-3.11-
P/OCF Ratio
-12.51-10.35-3.18-
EV/EBITDA Ratio
-8.21-7.65-0.840.35
EV/EBIT Ratio
-8.10-7.52-0.840.34
EV/FCF Ratio
-11.70-9.20-1.570.50
Debt / Equity Ratio
0.090.060.060.08
Debt / EBITDA Ratio
-0.05-0.07-0.05-0.01
Debt / FCF Ratio
-0.08-0.08-0.10-0.02
Quick Ratio
3.276.895.561.81
Current Ratio
4.037.986.522.26
Return on Equity (ROE)
-147.10%-103.50%-198.90%-830.70%
Return on Assets (ROA)
-113.60%-80.80%-141.90%-168.60%
Return on Capital (ROIC)
-164.83%-95.72%-99.75%-583.92%
Earnings Yield
-16.28%-11.89%-60.28%-
FCF Yield
-11.32%-9.75%-32.11%-
Buyback Yield / Dilution
-19.64%-59.14%-13.63%-
Total Shareholder Return
-19.64%-59.14%-13.63%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).